KLOW 80mg

KLOW 80mg

Multi-peptide research formulation studied for inflammatory signaling modulation, cellular repair pathways, and tissue remodeling models.

Compound Overview

KLOW is a multi-peptide research blend composed of GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg). The formulation is studied in laboratory environments for its coordinated interaction across cellular repair, inflammatory signaling regulation, and extracellular matrix remodeling pathways.

GHK-Cu is a copper-binding tripeptide studied for its role in collagen synthesis, angiogenic signaling, and tissue regeneration pathways. BPC-157 is evaluated in research models for its influence on cellular repair mechanisms and nitric-oxide-related signaling systems. TB-500, derived from thymosin beta-4, is commonly studied for actin regulation, cellular migration pathways, and vascular signaling processes.

KPV, a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH), is examined in laboratory research for its interaction with inflammatory signaling pathways and immune-response regulation models. Combined peptide formulations such as KLOW are frequently included in research exploring coordinated peptide signaling across multiple biological repair systems.

Product Specifications

• Product Name: KLOW Research Blend
• GHK-Cu Content: 50mg
• BPC-157 Content: 10mg
• TB-500 Content: 10mg
• KPV Content: 10mg
• Total Peptide Content: 80mg per vial
• Form: Lyophilized peptide blend
• Intended Use: Research use only